

This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
The Brien Center accepts most public and private insurance plans. For those without coverage, a sliding fee scale ensures access to care. Services are designed to meet individual needs regardless of financial status.
Keenan House is a gender-specific recovery program for people recovering from addiction and mental health issues. It includes Keenan House for Men, Keenan House for Women, and Keenan House North. These homes offer structured, long-term care supporting residents in rebuilding their lives and community ties.
Residents receive evidence-based therapies such as individual counseling, group sessions, and medication-assisted treatment. Daily programming focuses on relapse prevention, parenting, and health education. Holistic supports—like 12-step meetings, exercise, and peer mentoring—foster self-esteem and life skills, helping residents pursue personal recovery goals.
Each Keenan House provides a home-like environment that encourages connection and peer support. Residents live in a structured setting that fosters stability and includes continuous staff guidance and recovery services. This supportive housing model helps individuals focus on healing, personal growth, and lasting recovery.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.

Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.